https://www.selleckchem.com/ATM.html
Pralatrexate is a cost-effective intervention with improved OS and incremental costs within the WTP limit. Pralatrexate could function as a new therapeutic option for patients suffering from life-threatening R/R PTCL. Pralatrexate is a cost-effective intervention with improved OS and incremental costs within the WTP limit. Pralatrexate could function as a new therapeutic option for patients suffering from life-threatening R/R PTCL. Assessing hospital mortality and its predictors is important as some of these can be prevented through appropriate inte
Like
Comment
Share
